 There is no consensus about the most effective therapy in the treatment of Guillain-Barré-syndrome: plasma exchange (PE) versus intravenous immunglobulin therapy. The present investigation examines the side effects of 155 plasma exchanges. Furthermore, the analysis of all expenses for both treatments will contribute to the discussion of the preferable treatment.  
